Skip to main content
Surgical Case Reports
Fig. 1 | Surgical Case Reports

Fig. 1

From: Fatal acquired coagulation factor V deficiency after hepatectomy for advanced hepatocellular carcinoma as a possible immune checkpoint inhibitor-related adverse event: a case report

Fig. 1

Preoperative contrast-enhanced computed tomography (CT) of the arterial phase. Huge hepatocellular carcinoma located in the hepatic hilum, before (A) and after (B) atezolizumab and bevacizumab treatment. The tumor viability seemed reduced; note that the CT attenuation number is diffusely decreased in B

Back to article page